Clinical Trials Directory

Trials / Completed

CompletedNCT06241586

A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis

A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis: A Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
271 (actual)
Sponsor
Tianjin Nankai Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The goal of this observational study is to compare patient outcomes between the groups of patients admitted before and after the full implementation of the novel surgical strategy in patients with necrotizing pancreatitis. The main question it aims to answer are: • the efficacy and safety of the novel surgical strategy To assess the efficacy and safety of the novel surgical strategy, all included patients were divided into two groups according to the timing of receiving treatment: 1) the early period group: patients admitted before January 2021 received the hybrid strategy of traditional and novel surgical strategies; and 2) the late period group: patients admitted during and after January 2021 received the complete novel surgical strategy.

Conditions

Interventions

TypeNameDescription
PROCEDUREThe novel PMMI surgical strategyImmediate drainagewas advocated within 24 hours once necrosis was diagnosed. During the treatment course, a hybrid approach was available by flexibly switching interventions. Open surgery was only applied when patients required emergency surgery. The minimally invasive surgery was selected based on the size, location, and maturity of the necrotic area and stepwise response to intervention. Repeated peritoneal purification was performed until the infected or devitalized tissue was controlled. Patients were subsequently discharged with a drainage catheter and readmitted at 7- to 10-day intervals to receive repeated planned surgery without postoperative irrigation. Patients received a whole-course assessment for individual patients at 7-day predetermined intervals.
PROCEDUREThe conventional step-up strategyInterventions were postponed until 4 weeks after the onset of pancreatitis in line with international guidelines unless the patient showed evidence of progressive clinical deterioration despite the use of maximal supportive care. Patients underwent CT-guided percutaneous catheter drainage as the first step. Treatment response was evaluated after 3 days. If drainage was clinically unsuccessful, a VARD procedure was performed. Similarly, open surgery, which was described by Beger et al., was performed if the VARD procedure failed. Postoperative continuous lavage is performed as a routine procedure.

Timeline

Start date
2019-01-01
Primary completion
2021-12-31
Completion
2022-10-01
First posted
2024-02-05
Last updated
2024-02-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06241586. Inclusion in this directory is not an endorsement.